Brevan Howard Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Sell
10,664
-2,080
-16% -$50.8K ﹤0.01% 1736
2025
Q4
$288K Sell
12,744
-6,938
-35% -$151K ﹤0.01% 1391
2025
Q3
$396K Sell
19,682
-45,196
-70% -$757K ﹤0.01% 1408
2025
Q2
$926K Buy
64,878
+33,225
+105% +$388K 0.01% 1106
2025
Q1
$332K Sell
31,653
-68,582
-68% -$776K ﹤0.01% 834
2024
Q4
$1.21M Buy
100,235
+48,545
+94% +$635K 0.01% 381
2024
Q3
$759K Buy
51,690
+12,788
+33% +$178K 0.01% 547
2024
Q2
$561K Buy
+38,902
New +$622K 0.01% 566

Other funds holding ELAN

Brevan Howard Capital Management's ELAN Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Elanco Animal Health (ELAN) stake by 16% in Q1 2026, selling an estimated $50.8K and leaving 10,664 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Brevan Howard Capital Management first reported a position in ELAN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.21M in Q4 2024. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Brevan Howard Capital Management held 10,664 shares of Elanco Animal Health worth $255K as of Q1 2026.
  • Brevan Howard Capital Management sold 2,080 Elanco Animal Health shares in Q1 2026, an estimated $50.8K.
  • Elanco Animal Health made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1736 holding.
  • Brevan Howard Capital Management first reported a position in Elanco Animal Health in Q2 2024 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Elanco Animal Health position peaked at $1.21M in Q4 2024.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.